Nano delivery of simvastatin targets liver sinusoidal endothelial cells to remodel tumor microenvironment for hepatocellular carcinoma.
Zhuo YuJianfeng GuoYun LiuMenglin WangZhengsheng LiuYueqiu GaoLeaf HuangPublished in: Journal of nanobiotechnology (2022)
These findings reveal an immune-based therapeutic mechanism of simvastatin for remodeling immunosuppressive tumor microenvironment, therefore providing a novel strategy in treating HCC.